Biotech RadarJobs updated

COMPANY

AngioDynamics

HQ: Latham, NY source · angiodynamics.com ↗

FDA-cleared device company Clinical Phase 3

AngioDynamics offers three different angiographic catheter lines to meet physicians’ procedural needs. To aid physicians in percutaneous drainage procedures, AngioDynamics offers the Total Abscession Drainage Catheters. From public records Source · Jul 14, 2026

Keywords: catheter Prostate Cancer Peripheral Arterial Disease Liver Ablation Adult Liver Cancer Pulmonary Embolism Stage III Pancreatic Cancer Infrainguinal Peripheral Artery Disease Pulmonary Embolism Acute Infective Endocarditis Peripheral Arterial Diseases Hepatocellular Carcinoma Colorectal Adenocarcinoma Metastatic in the Liver Acute Pulmonary Embolism (PE) Acute Pulmonary Embolism Chronic Venous Insufficiency Heart Disease Pancreatic Adenocarcinoma Acute Kidney Injury Acute Renal Failure Chronic Kidney Disease Varicose Veins Venous Insufficiency Non Small Cell Lung Cancer Pulmonary Metastases Irreversible Electroporation AURYON Atherectomy System AlphaReturn Blood Management System AngioVac System AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE VenaCure EVLT 400 µm fiber Procedure Kit AngioVac NanoKnife Low Energy Direct Current (LEDC) System Ablation Benephit catheter for Targeted Renal Therapy

Location: Latham, NY · source · Oct 15, 2026

Profile checked Oct 10, 2026

22Trials (company is sponsor)

Timeline

  1. Trial start Not phased (device or behavioral study): Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH) source ↗
  2. Trial start Not phased (device or behavioral study): Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone in Europe source ↗
  3. Trial start Not phased (device or behavioral study): Percutaneous AngioVac Vegetation Extraction (PAVE) to Remove Right Heart Vegetations in Patients With Infective Endocarditis source ↗
  4. Trial start Not phased (device or behavioral study): Acute Pulmonary Embolism Treatment With the AlphaVac Multipurpose Mechanical Aspiration System and the AlphaReturn Blood Management System: Evaluation of Safety and Effectiveness source ↗
  5. Trial start Not phased (device or behavioral study): International Study on Treatment of Liver (HCC) Patients With IRE source ↗
  6. Trial start Not phased (device or behavioral study): International Study on Treatment of Patients With Metastatic Colorectal Liver Lesions Patients With IRE source ↗
  7. Trial start Not phased (device or behavioral study): Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneous Mechanical Aspiration Thrombectomy for Treatment of Acute Pulmonary Embolism Using the AlphaVac Multipurpose Mech source ↗
  8. Trial start Phase 4: Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone source ↗
  9. Trial start Not phased (device or behavioral study): Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism source ↗
  10. Trial start Not phased (device or behavioral study): Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue source ↗
  11. Trial start Not phased (device or behavioral study): Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients source ↗
  12. Trial start Phase 3: A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer source ↗
  13. Trial start —: Post-Market Registry of AURYON Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease source ↗
  14. Trial start —: A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer source ↗
  15. Trial start —: Initial Experience With the AngioVac Venous Drainage Cannula source ↗
  16. Trial start Not phased (device or behavioral study): SeCure Endovenous Laser Treatment Study source ↗
  17. Trial start Not phased (device or behavioral study): The PROOF Study: The PICC Related Obstruction Of Flow Study source ↗
  18. Trial start Phase 2: NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic Cancer source ↗
  19. Trial start Not phased (device or behavioral study): Comparison Study for Safety and Efficacy of Two Devices for the Treatment of the Great Saphenous Vein source ↗
  20. Trial start —: Post-Market Observation Study of Intra-renal Drug Delivery (PROVIDE) source ↗
  21. Trial start Not phased (device or behavioral study): Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC) source ↗
  22. Trial start Phase 2: Radiofrequency Ablation of Pulmonary Tumors Response Evaluation source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 22

RecordTitlePhaseStatusStartPrimary completion
NCT07640776Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)Not phased (device or behavioral study)Not yet recruiting2026-092027-12 (estimated)
NCT04972097Pivotal Study of the NanoKnife System for the Ablation of Prostate TissueNot phased (device or behavioral study)CompletedMar 29, 2022Aug 14, 2024 (actual)
NCT04229563Post-Market Registry of AURYON Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery DiseaseNot listedCompletedAug 4, 2020Mar 17, 2021 (actual)
NCT07280247Acute Pulmonary Embolism Treatment With the AlphaVac Multipurpose Mechanical Aspiration System and the AlphaReturn Blood Management System: Evaluation of Safety and EffectivenessNot phased (device or behavioral study)RecruitingMar 30, 20262026-12 (estimated)
NCT07282002Percutaneous AngioVac Vegetation Extraction (PAVE) to Remove Right Heart Vegetations in Patients With Infective EndocarditisNot phased (device or behavioral study)Not yet recruiting2026-042026-11 (estimated)
NCT07472439Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone in EuropeNot phased (device or behavioral study)Not yet recruiting2026-052029-05 (estimated)
NCT06777901Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty AlonePhase 4RecruitingApr 21, 20252029-02 (estimated)
NCT07192731International Study on Treatment of Liver (HCC) Patients With IRENot phased (device or behavioral study)Not yet recruiting2026-022028-02 (estimated)
NCT07191548International Study on Treatment of Patients With Metastatic Colorectal Liver Lesions Patients With IRENot phased (device or behavioral study)Not yet recruiting2026-022028-02 (estimated)
NCT06697314Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneous Mechanical Aspiration Thrombectomy for Treatment of Acute Pulmonary Embolism Using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 SystemNot phased (device or behavioral study)RecruitingJun 15, 20252028-06 (estimated)
NCT03899636A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic CancerPhase 3Active, not recruitingFeb 23, 20212025-04 (estimated)
NCT03899649A Registry Study of NanoKnife IRE for Stage 3 Pancreatic CancerNot listedActive, not recruitingMay 8, 20192025-04 (estimated)
NCT05318092Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary EmbolismNot phased (device or behavioral study)CompletedOct 19, 2022Jan 4, 2024 (actual)
NCT01972867Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk PatientsNot phased (device or behavioral study)Unknown status (ClinicalTrials.gov)May 13, 2021Nov 1, 2022 (actual)
NCT02215369SeCure Endovenous Laser Treatment StudyNot phased (device or behavioral study)Completed2015-012018-03 (actual)
NCT01921114The PROOF Study: The PICC Related Obstruction Of Flow StudyNot phased (device or behavioral study)Terminated2013-102014-07 (actual)
NCT02775565Initial Experience With the AngioVac Venous Drainage CannulaNot listedCompleted2016-022016-09 (actual)
NCT01369420NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic CancerPhase 2Completed2011-052011-12 (actual)
NCT01064895Post-Market Observation Study of Intra-renal Drug Delivery (PROVIDE)Not listedTerminated2010-022011-12 (actual)
NCT01078415Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC)Not phased (device or behavioral study)Completed2010-022013-01 (actual)
NCT01173419Comparison Study for Safety and Efficacy of Two Devices for the Treatment of the Great Saphenous VeinNot phased (device or behavioral study)Withdrawn2010-072011-02 (estimated)
NCT00690703Radiofrequency Ablation of Pulmonary Tumors Response EvaluationPhase 2Completed2001-072006-12 (actual)
Feedback